Skip to main content

Claremont Financial Group, Inc.

Location
CLAREMONT, CA
Portfolio Value
Micro $5,974,589
Diversification
Highly concentrated
Filing Date
Global Rank
#6,509 / 6,765 ▲ 205 · as of Mar 2022
Top Industry
Drug Manufacturers - General 26.3%
3Y Alpha vs SPY
+3.0%
Period ended 4 years ago
Filed Aug 15, 2022 · 3y
2 quarters · since Dec 2021

Clone Performance

Jul 2023–Jul 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio
+89.6%
SPY
+76.5%
Annualised alpha
+2.9%
Max drawdown
−21.4%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

24 positions · as of Mar 31, 2022 · Δ vs Dec 31, 2021
Top Position
66.7%
+29.7 pts
Top 5
85.3%
−14.7 pts
Top 10
93.9%
−6.1 pts
HHI
4,584
Dec 2021 → Mar 2022 · range 2,872 – 4,584
Highly concentrated+1,712

Portfolio Trend

2 quarters · across all stocks

Sector Breakdown

As of Mar 31, 2022
Sector % Portfolio Value
Unclassified 76.9% $4,595,237
Industrials 7.0% $421,023
Healthcare 7.0% $415,750
Technology 3.6% $213,365
Consumer Cyclical 1.8% $109,513
Basic Materials 1.7% $99,598
Consumer Defensive 0.8% $50,158
Energy 0.8% $46,569
Communication Services 0.3% $17,704
Financial Services 0.1% $5,672

Last Quarter's Activity

Export CSV
Mar 31, 2022 vs Dec 31, 2021

Added To

Positions the filer increased
2 positions
Ticker Δ Shares Shares Value Open

Trimmed

Positions the filer reduced
1 positions
Ticker Δ Shares Shares Value Open

New Positions

Positions the filer opened this quarter
20 positions
Ticker Shares Value Open

Sold Out

Positions the filer fully exited
1 positions
Ticker Shares Value Open

Portfolio Positions

Export CSV View 13F filing
24 positions · $5,974,589 total · as of Mar 31, 2022
Ticker Company Shares Value (USD) % of Portfolio History